Ductal Carcinoma In Situ: Treatment Update and Current Trends
- 15 September 2015
- journal article
- review article
- Published by Springer Nature in Current Oncology Reports
- Vol. 17 (11) , 48
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- DCIS Treated with Excision Alone Using the National Comprehensive Cancer Network (NCCN) GuidelinesAnnals of Surgical Oncology, 2013
- A Multigene Expression Assay to Predict Local Recurrence Risk for Ductal Carcinoma In Situ of the BreastJNCI: Journal of the National Cancer Institute, 2013
- Cancer statistics, 2013CA: A Cancer Journal for Clinicians, 2013
- Long-Term Outcomes of Invasive Ipsilateral Breast Tumor Recurrences After Lumpectomy in NSABP B-17 and B-24 Randomized Clinical Trials for DCISJNCI: Journal of the National Cancer Institute, 2011
- Ductal carcinoma in situ treated with breast‐conserving surgery and accelerated partial breast irradiationCancer, 2010
- Ductal carcinoma in situ: trends in treatment over time in the USBreast Cancer Research and Treatment, 2010
- Biologic and immunologic effects of preoperative trastuzumab for ductal carcinoma in situ of the breastCancer, 2010
- Pathologic and biologic response to preoperative endocrine therapy in patients with ER-positive ductal carcinoma in situBMC Cancer, 2009
- Role for Intraoperative Margin Assessment in Patients Undergoing Breast-Conserving SurgeryAnnals of Surgical Oncology, 2007
- Initial Outcomes for Patients Treated on the American Society of Breast Surgeons MammoSite Clinical Trial for Ductal Carcinoma-In-Situ of the BreastAnnals of Surgical Oncology, 2006